AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Nexospas 500mg Injection

Prescription Icon
Prescription Required

Marketer

Albia Biocare

Salt Composition

Tranexamic Acid (500mg)

Overview Nexospas 500mg Injection

Tranexamic acid 500mg injection is indicated for hemorrhage management. It aids in preventing or minimizing blood loss associated with dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and various surgical procedures involving the oral cavity, prostate, or bladder. This antifibrinolytic medication functions by inhibiting clot dissolution, thus facilitating hemostasis. Administration should always be under medical guidance. Patients with known hypersensitivity to this injection should avoid its use. Frequently reported adverse effects include local injection site reactions, fatigue, musculoskeletal discomfort, and nasal stuffiness. Pre-existing cardiac surgery or renal impairment warrants disclosure to your physician. This injection is generally considered safe during pregnancy and lactation, and its use is not contraindicated in individuals with hepatic disease.

Uses of Nexospas 500mg Injection

Managing Hemorrhage

Major Benefits of Nexospas 500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Nexospas 500mg Injection:

  • Joint pain
  • Headache
  • Back pain
  • Vomiting
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Muscle cramp
  • Anemia (low number of red blood cells)
  • Lightheadedness

How to use Nexospas 500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Nexospas 500mg Injection works:

Fibrinolysis inhibitor Nexospas 500mg injection helps manage heavy menstrual bleeding and post-surgical hemorrhage by inhibiting clot dissolution.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Nexospas 500mg Injection and alcohol can result in significant sedation.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the administration of Nexospas 500mg Injection to pregnant individuals is absent. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Nexospas 500mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Nexospas 500mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

For individuals with impaired kidney function, administering Nexospas 500mg Injection requires careful consideration. Dosage modification of Nexospas 500mg Injection might be necessary. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Nexospas 500mg Injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.

What if you forget to take Nexospas 500mg Injection :

Omit a Nexospas 500mg Injection dose? Seek your physician's advice.

Facts to Know About Nexospas 500mg Injection

LabelValue
Type of Compound Protein Building Blocks and Related Compounds
Addictive None.
Treatment Category Hematological

FAQs on Nexospas 500mg Injection

Intramuscular administration of Nexospas 500mg Injection is contraindicated. The medication must be administered intravenously via slow injection to mitigate adverse reactions.
All medications carry the potential for adverse reactions; however, the likelihood of these is reduced with proper usage. The advantages of medication typically outweigh the risks of side effects. In rare instances, Nexospas 500mg Injection may produce severe, potentially life-threatening side effects, including anaphylaxis (characterized by skin rash, respiratory distress, and facial, oral, lip, or eyelid swelling), thrombosis, or visual disturbances. Always seek medical advice prior to commencing treatment and adhere precisely to prescribed instructions.
Nexospas 500mg Injection facilitates blood coagulation, reducing hemorrhaging. Nevertheless, thrombosis in the deep leg veins (DVT) may occur infrequently. While studies suggest contributing factors beyond the injection itself, DVT appears more prevalent among female recipients of Nexospas 500mg. Physician consultation prior to commencing treatment, along with meticulous adherence to prescribed instructions, is strongly recommended.
Long-term use of Nexospas 500mg Injection may affect color vision. Therefore, regular eye examinations are recommended throughout treatment. Report any visual changes to your physician immediately. They may discontinue the medication and prescribe an alternative if necessary.
Nexospas 500mg Injection facilitates hemostasis. While uncommon, it may, in rare instances, lead to the formation of a blood clot that migrates to the lungs (pulmonary embolism), potentially resulting in death. Although infrequent, pulmonary embolism as an adverse reaction to Nexospas 500mg Injection is more likely with overdose, prolonged immobility, or in predisposed patients. Contributing factors beyond the medication itself may also elevate this risk.
A single 500mg dose of Nexospas Injection may be administered with or without food, accompanied by water. The injection should be ingested whole; crushing or chewing is not advised.
Treatment length and dosage for this medication vary depending on the diagnosed condition. In cases of severe menstrual bleeding, a typical course lasts five days. However, for other ailments, the physician may prescribe a shorter or longer treatment period.
Nexospas 500mg Injection does not impair fertility. Prescribed for excessive menstrual bleeding, studies indicate it doesn't disrupt ovulation. Consequently, it's not a contraceptive and won't reduce pregnancy likelihood.
Indeed, Nexospas 500mg injections are suitable for treating epistaxis. Their action promotes blood coagulation and hemostasis. For recurrent nosebleeds, a course of treatment lasting up to one week may be considered.
Nexospas 500mg Injection
45
MRP 55
18% off